Patents by Inventor Jennifer Visich

Jennifer Visich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ADMINISTERING BETA7 INTEGRIN ANTAGONISTS
    Publication number: 20220403033
    Abstract: Methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of administering integrin beta7 antagonists, such as anti-beta7 antibodies. In addition, particular dosing regimens, including dosing regimens comprising subcutaneous administration and administration using self-inject devices are provided.
    Type: Application
    Filed: February 3, 2022
    Publication date: December 22, 2022
    Applicant: GENENTECH, INC.
    Inventors: Banmeet Anand, Eric Stefanich, Meina Tang, Jennifer Visich, Marna Williams, Sharon O'Byrne
  • METHODS OF ADMINISTERING BETA7 INTEGRIN ANTAGONISTS
    Publication number: 20210238288
    Abstract: Methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of administering integrin beta7 antagonists, such as anti-beta7 antibodies. In addition, particular dosing regimens, including dosing regimens comprising subcutaneous administration and administration using self-inject devices are provided.
    Type: Application
    Filed: February 4, 2020
    Publication date: August 5, 2021
    Applicant: GENENTECH, INC.
    Inventors: Banmeet Anand, Eric Stefanich, Meina Tang, Jennifer Visich, Marna Williams, Sharon O'Byrne
  • Methods for treating autoimmune diseases using a TACI-Ig fusion molecule
    Patent number: 8784812
    Abstract: In various embodiments, the present invention provides methods and compositions for treatment of autoimmune diseases, including rheumatoid arthritis, for example comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule. In one embodiment, the TACI-Ig fusion molecule is administered in amount sufficient to slow, suppress or inhibit proliferation-inducing functions of BlyS and APRIL.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: July 22, 2014
    Assignees: Zymogenetics, Inc., Ares Trading S.A.
    Inventors: Herve Broly, Jennifer Visich, Ivan Nestorov, Sharon Busby, Jane Gross
  • METHODS OF ADMINISTERING BETA7 INTEGRIN ANTAGONISTS
    Publication number: 20140120084
    Abstract: Methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of administering integrin beta7 antagonists, such as anti-beta7 antibodies. In addition, particular dosing regimens, including dosing regimens comprising subcutaneous administration and administration using self-inject devices are provided.
    Type: Application
    Filed: September 24, 2013
    Publication date: May 1, 2014
    Applicant: GENENTECH, INC.
    Inventors: Banmeet Anand, Eric Stefanich, Meina Tang, Jennifer Visich, Marna Williams, Sharon O'Byrne
  • DOSING METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-Ig FUSION PROTEIN SUCH AS ATACICEPT
    Publication number: 20090186040
    Abstract: In various embodiments, the present invention provides methods, compositions, dosing, and administration schedules for treatment of autoimmune diseases, including systemic erythematosus (SLE), for example, comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule such as atacicept. In one embodiment, the TACI-Ig fusion molecule is administered in amount sufficient to slow, suppress or inhibit proliferation-inducing functions of BLyS and APRIL, in particular the use of multiple administrations of the fusion molecule at relatively low dose over the course of the treatment.
    Type: Application
    Filed: June 13, 2008
    Publication date: July 23, 2009
    Inventors: Sharon J. Busby, Jane A. Gross, Jennifer Visich, Ivan Nestorov, Alain Munafo, Orestis Papasouliotis, Claudia Pena Rossi
  • METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-IG FUSION MOLECULE
    Publication number: 20070274984
    Abstract: In various embodiments, the present invention provides methods and compositions for treatment of autoimmune diseases, including rheumatoid arthritis, for example comprising administering to a patient in need of such treatment a TACI-Ig fusion molecule. In one embodiment, the TACI-Ig fusion molecule is administered in amount sufficient to slow, suppress or inhibit proliferation-inducing functions of BlyS and APRIL.
    Type: Application
    Filed: May 15, 2007
    Publication date: November 29, 2007
    Applicants: ARES TRADING S.A., ZYMOGENETICS, INC.
    Inventors: Herve Broly, Jennifer Visich, Ivan Nestorov, Sharon Busby, Jane Gross